Guardant Health, Inc. (GH)

Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	902.57	739.02	563.95	449.54	373.65	286.73
Revenue Growth (YoY)	30.38%	31.04%	25.45%	20.31%	30.31%	33.75%
Cost of Revenue	327.11	289.8	227.05	156.33	122.91	92.54
Gross Profit	575.46	449.22	336.9	293.21	250.74	194.2
Selling, General & Admin	658.32	545.06	451.03	463.78	398.52	299.28
Research & Development	359.47	347.75	367.19	373.81	263.22	149.86
Operating Expenses	1,018	892.81	818.22	837.59	661.74	449.15
Operating Income	-442.33	-443.59	-481.33	-544.38	-411	-254.95
Interest Expense	-3.36	-2.58	-2.58	-2.58	-2.58	-4.77
Interest & Investment Income	35.72	53.69	35.37	6.07	3.93	10.17
Other Non Operating Income (Expenses)	14.62	1.8	2.52	-99.51	0.18	3.64
EBT Excluding Unusual Items	-395.36	-390.69	-446.02	-640.4	-409.47	-245.9
Gain (Loss) on Sale of Investments	-2.18	-44.4	50.66	-13.05	-	-
Legal Settlements	-	-	-83.4	-	-	-
Other Unusual Items	-0.08	-	-	-	25	-
Pretax Income	-397.61	-435.09	-478.76	-653.45	-384.47	-245.9
Income Tax Expense	1.18	1.28	0.69	1.14	0.3	0.38
Earnings From Continuing Operations	-398.79	-436.37	-479.45	-654.59	-384.77	-246.28
Minority Interest in Earnings	-	-	-	-	-20.9	-7.5
Net Income	-398.79	-436.37	-479.45	-654.59	-405.67	-253.78
Net Income to Common	-398.79	-436.37	-479.45	-654.59	-405.67	-253.78
Shares Outstanding (Basic)	124	123	112	102	101	98
Shares Outstanding (Diluted)	124	123	112	102	101	98
Shares Change (YoY)	2.22%	9.61%	9.60%	0.85%	3.91%	7.62%
EPS (Basic)	-3.21	-3.56	-4.28	-6.41	-4.00	-2.60
EPS (Diluted)	-3.21	-3.56	-4.28	-6.41	-4.00	-2.60
Free Cash Flow	-262.23	-274.94	-345.46	-386.92	-284.05	-140.1
Free Cash Flow Per Share	-2.11	-2.24	-3.08	-3.79	-2.80	-1.44
Gross Margin	63.76%	60.79%	59.74%	65.22%	67.11%	67.73%
Operating Margin	-49.01%	-60.02%	-85.35%	-121.10%	-110.00%	-88.92%
Profit Margin	-44.18%	-59.05%	-85.02%	-145.61%	-108.57%	-88.51%
Free Cash Flow Margin	-29.05%	-37.20%	-61.26%	-86.07%	-76.02%	-48.86%
EBITDA	-402.19	-401.21	-438.44	-508.42	-388.73	-238.89
EBITDA Margin	-44.56%	-54.29%	-77.75%	-113.10%	-104.04%	-83.31%
D&A For EBITDA	40.14	42.39	42.88	35.96	22.27	16.07
EBIT	-442.33	-443.59	-481.33	-544.38	-411	-254.95
EBIT Margin	-49.01%	-60.02%	-85.35%	-121.10%	-110.00%	-88.92%
Revenue as Reported	739.02	739.02	563.95	449.54	373.65	286.73
Advertising Expenses	-	-	-	-	2.4	1.2

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q